Articles tagged with Antivirals
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers found that eltrombopag boosted platelet counts in a majority of patients with low platelet counts and cirrhosis due to HCV infection, allowing most to continue or start conventional antiviral treatment. The study's results are an important development for people infected with the hepatitis C virus worldwide.
A study found that antiviral medications significantly reduced the risk of death from flu in hospitalized adults, even when given up to four days after symptom onset. The research supports the use of antivirals for treating hospitalized patients with influenza.
The report warns that inadequate pandemic planning, including poor on-the-ground administration and delivery of antivirals and vaccines, could threaten EU security. The survey found that few countries have defined plans for distribution of antivirals or specific guidance on vaccine storage and administration.
A study found that Tamiflu is not removed or degraded during normal sewage treatment, leading to high levels of the drug in surrounding waters. This increases the risk of influenza viruses developing resistance to the medication, posing a threat to public health.
Research finds patients with lower levels of HCV antibody titer tend to have a brighter clinical outcome. Co-infection by hepatitis B and A viruses is associated with a higher possibility of self recovery, possibly due to interference with virus replication.
General Practitioners (GPs) are still over-prescribing antibiotics for common infections like sore throats and sinusitis, hindering efforts to combat antibiotic resistance. The analysis of the world's largest primary care database found that prescriptions for these conditions rose to 80% despite guidance warnings.
A new survey reveals that chronic hepatitis B patients often misunderstand the nature of their disease and its treatment. Despite being aware of the long-term consequences of the virus, many patients do not comply with their medication regimens, highlighting the need for improved patient education. The study suggests that enhanced pati...
Researchers will continue to study the antiviral, anti-inflammatory and immune-boosting mechanisms of Echinacea and Hypericum. The center aims to improve understanding of the characteristics of extracts that contribute to human health benefits.
Researchers at St. Jude Children's Research Hospital found that intramuscular injections of peramivir for 8 days protected mice from lethal H5N1 influenza virus infection and inhibited virus replication. This study supports the use of peramivir to control influenza during a pandemic.
A recent study in Japan found partial resistance to neuraminidase inhibitors among influenza B viruses, which may have implications for treatment and prevention strategies. The emergence of these resistant variants poses a significant concern, as they can cause infections with no difference in duration or clinical outcome.
The UGA-Emory collaboration will study influenza virus adaptation, transmission, and human immune responses. Researchers will also explore the genetic factors of flu spread and develop new antivirals.
A mathematical model suggests that widespread use of antiviral drugs like oseltamivir can quickly spread resistant viruses, even if they emerge rarely. Prophylaxis and treatment with oseltamivir would still delay the onset of the pandemic and reduce its total size.
A mathematical model predicts that international cooperation on sharing antiviral drugs is key to slowing down the spread of a bird flu pandemic. The 'reproductive number' of the virus plays a critical role in determining its potential for global spread.
Researchers found antiviral drugs highly effective in preventing seasonal flu illness, with oseltamivir at 81% efficacy. Treatment also reduced infectiousness, particularly with oseltamivir, but further studies are needed to confirm results.
Chronic kidney disease affects a significant portion of the UK population, particularly elderly individuals taking multiple medications. Healthcare professionals require specific guidance on using drugs that can cause or be altered by kidney disease, as 'use with caution' advice is often insufficient.
A new drug, eltrombopag, stimulates blood platelet production, enabling patients with low platelets to take standard antiviral medications. The trial found that 95% of patients responded with increased platelets and were able to start therapy.
A new study found that 30% of nations have not prioritized either vaccine nor drugs, while 49% prioritize antiviral drugs and 62% prioritize flu vaccines. The allocation decisions vary across countries, with healthcare workers consistently ranked top, but a wide variation in choosing next in line.
A study reviewing 45 national pandemic influenza plans found that countries have not consistently prioritized who should receive vaccines, antivirals, ventilators, face masks, and other critical resources. Healthcare workers are often prioritized, but with varying criteria among countries.
Researchers at the University of Wisconsin-Madison have discovered a novel peptide that effectively blocks influenza viruses, including deadly avian influenza, from entering host cells. The new finding offers a potential tool for preventing and treating influenza, which is losing its potency due to evolution.
Experimental drugs show promise against neuroAIDS, a growing concern despite best antivirals. New grant aims to protect brain from HIV-related nerve damage using compounds that counter toxins and reduce inflammation.
A comprehensive review of SARS treatment efficacy has found no evidence that any treatments were effective in treating the virus. The review examined 54 SARS treatment studies and 15 in-vitro studies but concluded that none of the treatments were successful.
Researchers at UT Southwestern Medical Center found that giving pregnant women with a history of genital herpes an anti-viral drug significantly lowers the rate of C-sections needed to protect infants from becoming infected. The study, involving 338 women, showed a 69% reduction in clinical herpes simplex virus at delivery.
Researchers have developed a new approach to target different diseases using short interfering RNA (siRNA) with tailored cellular properties. Human trials for siRNA-based anti-cancer and anti-viral treatments are currently underway in the USA and Europe, offering promising results.
The hepatitis C virus uses its protease activity to destroy a key antiviral signaling protein called MAVS, preventing infected cells from producing type 1 interferon. This allows the virus to evade the immune system and persist indefinitely, highlighting potential new treatment strategies.
A small study found that antiviral therapy with acyclovir and valacyclovir can significantly reduce postherpetic neuralgia symptoms in patients with moderate to severe nerve pain following shingles. Eight out of 15 participants reported a significant reduction in pain after one month of treatment.
Researchers have discovered that the sweetgum tree contains significant amounts of shikimic acid, a key ingredient in the production of Tamiflu, a treatment for bird flu. This finding could help alleviate the global shortage of the drug, which has sparked concerns over a potential pandemic.
A new study calls for equal access to Hepatitis C treatment for young injection drug users, citing low reinfection and completion rates among this group. The research suggests that denying treatment due to substance use can be counterproductive, as it often fails to address underlying health issues.
A CDC study found alarmingly high adamantane resistance rates of 92% among influenza A viruses isolated from patients in the US. Rapid surveillance is critical to prevent resistant viruses from spreading, especially in vulnerable populations like nursing homes.
A new web model of influenza-host lifecycles will help scientists understand how the virus interacts with its host, enabling the design of more effective anti-viral drugs. The Reactome database outlines a typical virus life cycle and will be updated as research becomes available.
Researchers found that two classes of antivirals prevented flu symptoms but not infection, and did not stop virus shedding. Dr. Tom Jefferson advises against using these drugs for seasonal influenza control, citing low effectiveness and potential adverse effects.
The threat of an avian influenza pandemic is growing, but health professionals can take measures to contain outbreaks and prepare for potential human-to-human transmission. Quarantining methods, antiviral medications, and international cooperation are key strategies that can help prevent or mitigate a pandemic.
The Geneva summit aims to address critical issues in preventing the spread of H5N1 influenza, including early detection of new clusters, effective surveillance systems, and strategies to avoid resistance to antivirals. The event seeks to promote global cooperation and coordination in addressing this pandemic threat.
Researchers found HIV-infected patients with effective antiviral therapy continually replenish their viral reservoir. Latently infected CD4+ T cells may become reactivated, spreading virions to nearby cells. A new strategy involves co-administering a reagent to dampen cellular activation.
Researchers urge Australia to issue compulsory licences, enabling local generic manufacturers to produce antiviral therapies at lower costs. This move would enhance the country's preparedness for pandemics, particularly in high-risk regions like Indonesia.
A team of researchers has developed an antiviral inhibitor that is active against several coronaviruses, including those causing the common cold and SARS. The compound targets the main protease enzyme, which is crucial for viral replication, and shows promise as a potential treatment for coronavirus-related diseases.
Researchers found that early intervention could slow the pandemic by reducing morbidity until a well-matched vaccine is produced. A combination of targeted antiviral drugs, quarantine, and prevaccination was effective in containing outbreaks with relatively moderate viral reproductive numbers.
A new computer model developed by Howard Hughes Medical Institute researchers can predict the spread of a potential influenza pandemic and identify effective containment strategies. The model uses demographic information and data on past influenza pandemics to simulate the virus's transmission and track its spread.
UCSB has been awarded two NIH Program of Excellence (PEN) grants in nanotechnology, totaling $25.5 million, to develop nanoscale agents for diagnosing and treating pulmonary artery disease and detecting vulnerable plaque. The projects aim to create targeted nanoparticles that can deliver diagnostic systems and therapeutic agents direct...
Researchers at Purdue University found that the flexible structure of WIN compounds allows them to shimmy into the proteins forming the virus' outer shell and alter them. This could potentially stop the infection process. The team believes WIN compounds may be effective in stabilizing proteins, preventing the viral trap door from opening.
Scientists found that a small form of APOBEC3G repels HIV, while a large form is ineffective; blocking the small form makes resting cells susceptible to infection. The discovery shifts the paradigm on how HIV infects T cells.
Researchers discovered a new way to stop smallpox by inhibiting host cell signaling pathways. Inhibitors already used in human cancer therapy may have widespread applications in treating viral infections and protecting against smallpox.
Researchers developed a novel antiviral treatment using RNA interference to inhibit respiratory syncytial virus (RSV) infection in mice. The treatment, administered as a nasal drop or spray, successfully suppressed the virus's NS1 protein, preserving the host's natural antiviral defense.
The report recommends the development of antiviral drugs against smallpox due to its high lethality and ease of transmission. Research on poxvirus mechanisms and animal models is crucial to understand how the virus kills and develop effective treatments without using antiviral drugs.
The study showed that ganciclovir treatment lowers the risk of developing cancer and early organ rejection in kidney transplant patients. Ganciclovir offers dual benefits, extending patient life by reducing malignancy and improving graft survival with reduced rejection.
Researchers at University of Wisconsin-Madison have discovered a potent way to shut down viruses by introducing harmless molecules that mimic the virus's growth machinery, outperforming traditional antiviral strategies in inhibiting viral growth and creating drug-resistant strains.
Researchers found that recombinant interferons were effective against SARS-CoV replication, with interferon beta showing prophylactic protection and antiviral potential. Interferon alpha was less effective but could be a potential drug of choice in combination with other antiviral drugs.
Researchers at Purdue University have obtained the first-ever images of a developing dengue virus, revealing a complex developmental process that could lead to the discovery of new antiviral medicines. The immature particle is covered with protein spikes that flatten out as it matures into the infectious dengue virus.
Researchers at Frankfurt University Medical School have assessed the antiviral potential of five drugs against the SARS coronavirus. Glycyrrhizin, an antiviral agent proven to treat HIV-1 and hepatitis C, is the most active compound in inhibiting replication, with increased nitric oxide synthesis contributing to its effectiveness.
A long-term study found that administering oral antivirals reduced the risk of blindness and other serious eye effects in patients with eye shingles. Untreated patients experienced 8.9% adverse outcomes, while treated patients had only 2.1%. Timing of treatment also affected long-term outcomes.
Researchers found that a virus uses a protein called actin to destroy its own cells, allowing it to escape and infect other cells. The discovery provides new insights into viral infections and could lead to the development of antiviral agents.
Researchers at Cedars-Sinai Medical Center found that a cancer drug caused a virus to mutate so much it could no longer reproduce, becoming extinct. The treatment increases mutations in viral genomes, making it a promising approach to combat viruses.
A Stanford researcher found that vaccinating the entire population and using antiviral medications on those who get sick benefits society. The study found vaccination strategies were optimal in 95% of runs, with treatment of flu patients also benefiting 85% of the time.
Researchers at UCR discovered that animal cells use RNA silencing to protect themselves from viral infections, a mechanism also found in plants. This breakthrough could lead to new gene therapies and vaccine designs for treating recalcitrant human and animal viral diseases.
Researchers have developed a potent antiviral drug, HDP-CDV, that can block the replication of variola and orthopox viruses, including smallpox. The oral drug is 100 times more active than existing cidofovir and may be used to treat and prevent smallpox infections.
Researchers at Brookhaven Lab have identified a new approach to developing antiviral agents by targeting the protease enzyme used by adenoviruses. The three-pronged therapy approach may overcome drug resistance, as mutations affecting one site are less likely to affect others.
Researchers have visualized the atomic-scale structure of a selectivity filter in ion channels, revealing precise biochemical conditions for ion travel. This discovery may help understand genetic and biochemical abnormalities affecting ion channel proteins, such as long QT syndrome and cystic fibrosis.
A recent study from the University of California, San Francisco has discovered a novel mechanism by which the drug ribavirin kills viruses by generating excess mutations that overwhelm the virus. This unexpected finding may lead to the development of more effective anti-viral treatments for hepatitis C patients.
Researchers found that ribavirin increases the mutation rate of RNA viruses, pushing them into genetic meltdown and making them useless. This mechanism offers hope for designing more effective antiviral drugs.
Researchers at Harvard Medical School have made a breakthrough in treating multi-site brain cancers by combining tumor-attacking viruses with an approved chemotherapeutic drug. The treatment works by suppressing the immune system's antiviral response, allowing the virus to selectively kill malignant cells.
A new study by University of Michigan professor Dr. Arnold S. Monto found that zanamivir, an antiviral drug, is 67% effective in preventing laboratory-confirmed clinical influenza infection. The drug was also shown to be 84% effective in preventing laboratory-confirmed illnesses with fever.